Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Claridge


V.TLT

RE:RE:RE:RE:RE:RE:RE:200,000 Warrants Converted

Bionicblowjob ... We never ever saw you posting on the science, the...

June 15, 2019

V.TLT

RE:RE:RE:RE:RE:RE:200,000 Warrants Converted

Skier59 ... BionicBlowJob should have done his homework better before posting...

June 15, 2019

V.TLT

RE:RE:RE:RE:RE:200,000 Warrants Converted

For a guy that used to bash many posts/day, every single day under different...

June 15, 2019

V.TLT

Keytruda and its endless search for new immune inhibitors

It always amazes me the number of "satellite" drugs (mostly immune...

June 15, 2019

V.TLT

RE:Theralase Technologies as yet undiscovered

Gees!  Thought Hydrocarbss was going to delete his SH id! ... lollll __...

June 15, 2019

V.TLT

Targeting Hypoxia to Improve NSCLC Outcome

Considering these 2 articles below and the level of challenge and complexity...

June 14, 2019

V.TLT

Journal of the National Cancer Institute

Could be an interesting journal to publish in, to promote PDT/PDC, once we...

June 14, 2019

V.TLT

Guidelines to Evaluate Response to Treatment in Solid Tumors

2000, but still accurate in terms of guideline ... New Guidelines to...

June 14, 2019

V.TLT

IPO of the world's richest biopharma families

The amazing priviledge to already be in TLT ... An IPO will make one of...

June 14, 2019

V.TLT

RE:10 presentations on TLT's scientific platform in 10 days

Some of the 10 upcoming presentations: PDT School: Basic Sciences Friday...

June 13, 2019

V.TLT

PDT for Lung Cancer

2016 but very interesting paper from Roswell Park Institute. Photodynamic...

June 13, 2019

V.TLT

Top 10 pharma R&D budgets in 2018

Amazing what TLT did with its tiny 50M$ R&D budget since 2010 when...

June 13, 2019

V.TLT

Stopping cancer before it develops

Never take anything for granted.  But we still have time. Research...

June 13, 2019

V.TLT

RE:RE:RE:RE:RE:RE:Consolidation

Contrary to ours, that biotech is not listed on the stock exchange.  If...

June 13, 2019

V.TLT

RE:RE:RE:When Does Ph 2 First Patient Get Treated?

Clinical Trials - Some data Clinical Trials - Additional data

June 13, 2019

V.TLT

RE:RE:When Does Ph 2 First Patient Get Treated?

Mid-2015, ICON signed a deal with IBM to improve its clinical trial...

June 13, 2019

V.TLT

RE:News needed before the AGM

Do you really believe that there will not be any news before the AGM?

June 13, 2019

V.TLT

RE:When Does Ph 2 First Patient Get Treated?

We'll get a press release on that milestone, don't worry.  It...

June 13, 2019

V.TLT

UHN neurosurgeon Dr. Zadeh on the latest in Glioblastoma

From the one that plugged us to the first edition Neuro-Oncology Advances...

June 12, 2019

V.TLT

UHN Producing Results as the Whole World is Watching

That's pretty much what they're doing now with our technology...

June 12, 2019